BioCryst Pharmaceuticals
BCRXBioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug RAPIVAB was approved by FDA in Dec 2014.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at BioCryst Pharmaceuticals
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 5/18/2026 | Sell | Mckee, Amy E. | Director | $9.0 | $100,285 |
| 5/13/2026 | Sell | Barnes, Alane P. | Chief Legal Officer | $9.5 | $596,250 |
| 3/20/2026 | Sell | Heggie, Theresa | Director | $10.1 | $504,823 |
| 3/16/2026 | Sell | Barnes, Alane P. | Chief Legal Officer | $9.2 | $1,372,500 |
| 12/22/2025 | Sell | Barnes, Alane P. | Chief Legal Officer | $7.7 | $166,563 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)